Fer14 EXTRA - Men's formula

Fer14 extra - a férfi vitamin It is well-known that planned conception doesn't occur in approximately 15% of the marriages. Causes happening in male organisms are about half of the cases and in female organisms too. Spermatozoa are subjected to numerous harmful effects throughout men’s lives, such as environmental or lifestyle factors. It can often be beneficial even for healthy men to follow a diet that helps their bodies' cells maintain their biological functions. FER14 EXTRA is a food supplement that contains vitamins, amino acids, trace elements, and minerals in a concentrated form. They are involved in biological functioning of spermatozoa, therefore FER14 EXTRA supports their appropriate functioning.These substances: amino acids are arginine, taurine, vitamins are Vitamin B6, folic acid, beta-carotene, vitamin B12, vitamin C, vitamin E and the very important D3, the trace elements are zinc, selenium, and mineral and other supplements are magnesium, L-carnitine and coenzyme Q10. It is a scientifically proven fact that sperm formation and maturation takes about three months, so the recommended amount of FER14 EXTRA is 2 × 1 pill a day for at least three months, however, taking it constantly can make the condition of human organism even better and better. Selection of ingredients and quantification has been done accurately and reliably as it is supposed to be. This product can supply all vitamin an mineral needs of an adult considering that some of the ingredients get into the body by diverse nutrition as well. International medical journal claims that FER14 EXTRA has positive impacts on fertilizing ability of men.

Fer14 EXTRA - Men's formula

Why Unique?

  • It contains 14 kinds of substances, which play a role in sperm formation, development and maintenance of fertilizing potential
  • FER14 EXTRA makes it very simple to get a large, necessary amount and multiple kinds of active ingredients into the body at the same time
  • as a unique product among developed ones that maintain men’s fertility, in a tablet, Fer14 Extra contains taurine, which is one of the most important antioxidant agents of human cells, an amino acids with antioxidant properties. It also contains arginine, which is important in formation and maturation of spermatozoa, and coenzyme Q10, a factor with antioxidant properties, which also plays a role in formation and maturation of spermatozoa. Besides these, this product contains significant quantities of vitamins B6, B12, C, D3 and E, carnitine, beta-carotene, magnesium, zinc, selenium and folic acid

Recommended to

  • For men who wish to start a family, because the product can contribute to the physiologic function of sperm.
  • For men with certain types of prostatitis (prostate inflammation), and epididymitis (inflammation of epididymis) and for those have been through surgical treatment of varicocele (an abnormal enlargement of the veins around testicles) in order to promote cellular regeneration.
  • For middle-aged men, because the antioxidant ingredients can contribute neutralization of free radicals, therefore it might be able to slow down the aging-processes of cells.

Why recommendable?

Contains antioxidants, which might protect spermatozoa from certain harmful external impacts: Factors contributing to generation and maturation of spermatozoa: Factors contributing to production of male sex hormones: Substances influencing nucleic acid synthesis: Substances important in sperm cell motility:
  • Vitamins C- and E
  • beta-carotene
  • selenium
  • zinc
  • coenzyme Q10
  • taurin
  • arginine
  • vitamin B12
  • vitamin D3
  • folate
  • selenium
  • magnesium
  • beta-carotene
  • vitamin B6
  • vitamin B12
  • folate
  • coenzyme Q10
  • vitamin B12
  • vitamin D3
  • folate
  • zinc
  • L-carnitine
Recommended dose: Recommended daily dose: 2x1 tablets for 3 months. One pack contains a monthly portion (60 tablets).


The daily dose of Fer14 EXTRA contains:

Vitamin C
Vitamin E
Vitamin D3
Coenzyme Q10
Vitamin B6
Vitamin B12
250 mg
200 mg
200 mg
150 mg
120 mg
100,67 mg
25 µg
10 mg
14 mg
3,6 mg
1,5 mg
400 µg
35 µg
2,5 µg
1 box: HUF 14 700
Monthly dose
3 box: HUF 37 500
3 months dose
In case of orders outside of Hungary, the postage costs vary depending on the country and quantity. For the exact costs please, send us an email to: info@fer14.hu


  1. Agarwal A, Said TM. Carnitines and male infertility. Reprod Biomed Online. 2004; 8: 376-84
  2. Apgar J. Zinc and reproduction. Annu Rev Nutr 1985; 5: 43-68
  3. Aydin S, Inci O, Alagol B. The role of arginine, indomethacin and kallikrein in the treatment of oligoasthenospermia. Int Urol Nephrol 1995; 27: 199-202.
  4. Balercia G, Arnaldi G, Fazioli F, Serresi M, Alleva R, Mancini A, Mosca F, Lamonica GR, Mantero F, Littarru GP. Coenzyme Q10 levels in idiopathic and varicocele-associated asthenozoospermia. Andrologia 2002; 34: 107-11
  5. Balercia G, Mosca F, Mantero F, Boscaro M, Mancini A, Ricciardo-Lamonica G, Littarru G. Coenzyme Q(10) supplementation in infertile men with idiopathic asthenozoospermia: an open, uncontrolled pilot study. Fertil Steril 2004; 81: 93-8
  6. Bayer R. Treatment of infertility with vitamin E. Int J Fertil 1960; 5: 70-8.
  7. Bentivoglio G et al. Folinic acid in the treatment of human male infertility. Fert & Ster 1993; 60: 698-701.
  8. Carpino A, Siciliano L, Petroni MF, et al. Low seminal zinc bound to high molecular weight proteins in asthenozoospermic patients: evidence of increased sperm zinc content in oligoasthenozoospermic patients. Hum Reprod 1998; 13: 111-4.
  9. Cooper TG, Yeung CH. Recent biochemical approaches to post-testicular, epididymal contraception. Hum Reprod Update 1999; 5: 141-52
  10. Costa M, Canale D, Filicori M, et al. L-carnitine in idiopathic asthenozoospermia: a multicenter study. Andrologia 1994; 26: 155-9.
  11. Daher R et al. Relationship of increased homocysteine with copper, iron, and zinc concentrations in serum. Irish J Med Sci 1995; 164: Suppl 15.
  12. Danscher G, Hammen R, Fjerdingstad E, Rebbe H. Zinc content of human ejaculate and motility of sperm cells. Int J Androl 1978; 1: 576-81.
  13. Dawson EB, Harris WA, McGanity WJ. Effect of ascorbic acid on sperm fertility. Fed Proc 1983; 42: 531.
  14. Dawson EB, Harris WA, Powell LC. Relationship between ascorbic acid and male fertility. In: Aspects of Some Vitamins, Minerals and Enzymes in Health and Disease, ed. GH Bourne. World Rev Nutr Diet 1990; 62: 1-26.
  15. Dawson EB, Harris WA, Rankin WE, et al. Effect of ascorbic acid on male fertility. Ann N Y Acad Sci 1987; 498: 312-23.
  16. Dawson EB, Harris WA, Teter MC, Powell LC. Effect of ascorbic acid supplementation on the sperm quality of smokers. Fertil Steril 1992; 58: 1034-9.
  17. De Aloysio D, Mantuano R, Mauloni M, Nicoletti G. The clinical use of arginine aspartate in male infertility. Acta Eur Fertil 1982; 13: 133-67.
  18. De Rooij DG, Van Dissel-Emiliani FM, Van Pelt AM. Regulation of spermatogonial proliferation. Ann N Y Acad Sci 1989; 564: 140-53
  19. Dokmeci D. Oxidative stress, male infertility and the role of carnitines. Folia Med 2005; 47: 26-30
  20. Fraga CG, Motchnik PA, Shigenaga MK, et al. Ascorbic acid protects against endogenous oxidative DNA damage in human sperm. Proc Natl Acad Sci 1991; 88: 11003-6.
  21. Gagnon, C., Iwasaki, A., Lamirande, E.D., and Kovalski, N. Reactive Oxygen Species and Human Spermatozoa. Annals of the New York Academy of Sciences, 1991; 637: 436-44.
  22. Geva E, Bartoov B, Zabludovsky N, et al. The effect of antioxidant treatment on human spermatozoa and fertilization rate in an in vitro fertilization program. Fertil Steril 1996; 66: 430-4.
  23. Goverde HJ, Dekker HS, Janssen HJ, Bastiaans BA, Rolland R, Zielhuis GA: Semen quality and frequency of smoking and alcohol consumption - an explorative study. Int J Fertil 1995; 40: 135-8.
  24. Halliwell, B. Reactive Oxygen Species in Living Systems: Source, Biochemistry, and Role in Human Diseases. The American Journal of Medicine, Sept. 30, 1991; 91: 3C-14S-3C-22S.
  25. Hartoma TR, Nahoul K, Netter A. Zinc, plasma androgens and male sterility. Lancet 1977; 2: 1125-6.
  26. Hemingway RG. The influences of dietary intakes and supplementation with selenium and vitamin E on reproduction diseases and reproductive efficiency in cattle and sheep. Vet Res Commun 2003; 27: 159-74
  27. Hsu PC, Guo YL. Antioxidant nutrients and lead toxicity. Toxicology. 2002; 180: 33-44.
  28. Hunt CD, Johnson PE, Herbel JoL, Mullen LK. Effects of dietary zinc depletion on seminal volume and zinc loss, serum testosterone concentrations, and sperm morphology in young men. Am J Clin Nutr 1992; 56:148-57.
  29. Isoyama R et al. Clinical experience with methylcobalamin(CH3-B12) for male infertility. Hin Kiyo Acta Urol Jap1984; 30; 4581-586
  30. Isoyama R, Baba Y, Harada H, et al. Clinical experience of methyl-cobalamin (CH3-B12)/clomiphene citrate combined treatment in male infertility. Hinyokika Kiyo 1986; 32: 1177-83.
  31. Iwasaki, A., and Gagnon, C. Formation of Reactive Oxygen Species in Spermatozoa of Infertile Patients. Fertility and Sterility 1992; 57: 409-416.
  32. Jeulin C, Lewin LM. Role of free L-carnitine and acetyl-L-carnitine in post-gonadal maturation of mammalian spermatozoa. Hum Reprod Update 1996; 2: 87-102
  33. Kessopoulou E; Powers HJ; Sharma KK; Pearson MJ; Russell JM; Cooke ID; Barratt CL: A double-blind randomized placebo cross-over controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility. Fertil Steril (United States), Oct 1995, 64: 825-31
  34. Kumamoto Y, Maruta H, Ishigami J, et al. Clinical efficacy of mecobalamin in treatment of oligozoospermia. Acta Urol Jpn 1988; 34: 1109-32.
  35. Kvist U, Kjellberg S, Bjorndahl L, et al. Seminal fluid from men with agenesis of the Wolffian ducts: zinc-binding properties and effects on sperm chromatin stability. Int J Androl 1990; 13: 245-52.
  36. Kynaston HG, Lewis-Jones DI, Lynch RV, Desmond AD. Changes in seminal quality following oral zinc therapy. Andrologia 1988; 20: 21-2.
  37. Landau B et al. Folic acid levels in blood and seminal plasma of normo- and oligospermic patients prior and following folic acid treatment. Experimentia 1978; 34: 1301-2.
  38. Lenzi A, Lombardo F, Gandini L, Dondero F. Metabolism and action of L-carnitine: its possible role in sperm tail function. Arch Ital Urol Nefrol Androl 1992; 64: 187-96
  39. Lewin A, Lavon H. The effect of coenzyme Q10 on sperm motility and function. Mol Aspects Med 1997; 18 Suppl S213-9.
  40. Lewis, S., Boyle, P.M., McKinney, K.A., Young, I.S., Thompson, W. Total Antioxidant Capacity of Seminal Plasma is Different in Fertile and Infertile Men. Fertility and Sterility 1995; 64: 868-70
  41. Loft S, Poulsen HE. Cancer risk and oxidative DNA damage in man. J Mol Med. 1996; 74: 297-312.
  42. Mancini A, Milardi D, Conte G, Bianchi A, Balercia G, De Marinis L, Littarru GP. Coenzyme Q10: another biochemical alteration linked to infertility in varicocele patients? Metabolism 2003; 52: 402-6
  43. Marmar JL, Katz S, Praiss DE, DeBenedictis TJ. Semen zinc levels in infertile and postvasectomy patients and patients with prostatitis. Fertil Steril 1975:26:1057-63.
  44. Martin-Du Pan RC, Sakkas D. Is antioxidant therapy a promising strategy to improve human reproduction? Are anti-oxidants useful in the treatment of male infertility? Hum Reprod 1998; 13: 2984-5.
  45. Moncada ML, Vicari E, Cimino C, et al. Effect of acetylcarnitine treatment in oligoasthenospermic patients. Acta Europaea Fertilitatis 1992; 23: 221-4.
  46. Mroueh A. Effect of arginine on oligospermia. Fertil Steril 1970:21:217-9.
  47. Netter A, Hartoma R, Nahoul K. Effect of zinc administration on plasma testosterone, dihydrotestosterone and sperm count. Arch Androl 1981; 7: 69-73.
  48. Ng CM, Blackman MR, Wang C, Swerdloff RS. The role of carnitine in the male reproductive system. Ann N Y Acad Sci 2004; 1033: 177-88
  49. Omu AE, Dashti H, Al-Othman S. Treatment of asthenozoospermia with zinc sulphate: andrological, immunological and obstetric outcome. Eur J Obstet Gynecol Reprod Biol 1998;79:179-84.
  50. Petrosian AM, Haroutounian JE. Taurine as a universal carrier of lipid soluble vitamins: a hypothesis. Amino Acids 2000; 19: 409-21
  51. Prasad AS, Cossack ZT. Zinc supplementation and growth in sickle cell disease. Ann Intern Med 1984; 100: 367-71.
  52. Pryor JP, Blandy JP, Evans P, et al. Controlled clinical trial of arginine for infertile men with oligozoospermia. Br J Urol 1978; 50: 47-50.
  53. Rolf C, Cooper TG, Yeung CH, Nieschlag E. Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, double-blind study. Hum Reprod 1999; 14: 1028-33.
  54. Saaranen M, Suistomaa U, Kantola M, et al. Lead, magnesium, selenium and zinc in human seminal fluid: comparison with semen parameters and fertility. Hum Reprod 1987; 2: 475-9.
  55. Sandler B, Faragher B. Treatment of oligospermia with vitamin B12. Infertility 1984; 7: 133-8.
  56. Schacter A, Friedman S, Goldman JA, Eckerling B. Treatment of oligospermia with the amino acid arginine. Int J Gynaecol Obstet 1973; 11: 206-9.
  57. Schacter A, Goldman JA, Zukerman Z. Treatment of oligospermia with the amino acid arginine. J Urol 1973; 110: 311-3.
  58. Schaffer S, Takahashi K, Azuma J. Role of osmoregulation in the actions of taurine. Amino Acids 2000; 19: 527-46
  59. Scibona M, Meschini P, Capparelli S, et al. L-arginine and male infertility. Minerva Urol Nefrol 1994; 46: 251-3.
  60. Scott R, MacPherson A, Yates RWS, et al. The effect of oral selenium supplementation on human sperm motility. Br J Urol 1998; 82: 76-80.
  61. Sheweita SA, Tilmisany AM, Al-Sawaf H. Mechanisms of male infertility: role of antioxidants. Curr Drug Metab 2005; 6: 495-501
  62. Sinclair S. Male infertility: nutritional and environmental considerations. Altern Med Rev 2000; 5: 28-38
  63. Stankovic H, Mikac-Devic D. Zinc and copper in human semen. Clin Chim Acta 1976; 70: 123-6.
  64. Sumiya H et al. Medical treatment for idiopathic male infertility with oligospermia. Nishinihon J Urol
  65. Tanimura J. Studies on arginine in human semen. Part II. The effects of medication with L-arginine-HCl on male infertility. Bull Osaka Med School 1967; 13: 84-9.
  66. Tanimura J. Studies on arginine in human semen. Part III. The influences of several drugs on male infertility. Bull Osaka Med School 1967; 13: 90-100.
  67. Thiessen DD, Ondrusek G, Coleman RV. Vitamin E and sex behavior in mice. Nutr Metab 1975; 18: 116-9.
  68. Tikkiwal M, Ajmera RL, Mathur NK. Effect of zinc administration on seminal zinc and fertility of oligospermic males. Indian J Physiol Pharmacol 1987; 31: 30-4.
  69. Vezina D, Mauffette F, Roberts KD, Bleau G: Selenium-vitamin E supplementation in infertile men. Effects on semen parameters and micronutriental levels and distribution. Bio Trace Elem Res 1996, 53: 65-83
  70. Vitali G, Parente R, Melotti C. Carnitine supplementation in human idiopathic asthenospermia: clinical results. Drugs Exp Clin Res 1995; 21: 157-9.
  71. Wallock LM et al. Low seminal plasma folate concentrations are associated with low sperm density and count in male smokers and non.smokers. Fertility and Sterility 2001; 75: 252-9.
  72. Wong WY et al. Effects of folic acid and zinc sulfate on male factor subfertility: a double-blind, randomized, placebo-controlled trial. Fertility & Sterility 2002; 77: 491-8.
  73. Xuan W, Lamhonwah AM, Librach C, Jarvi K, Tein I.. Characterization of organic cation/carnitine transporter family in human sperm. Biochem Biophys Res Commun 2003; 306: 121-8.
  74. Zhang JP et al. Effect of smoking on semen quality of infertile men in Shandong, China. Asian J Androl 2000; 2: 143-6.
  75. Machtens S, Ckert S, Stief CG, Tsikas D, Frlich JC, Jonas U: Effects of various nitric oxide-donating drugs on adrenergic tension of human seminal vesicles in vitro. Urology. 2003 Feb;61(2):479-83.
  76. Omu AE, Al-Bader AA, Dashti H, Oriowo MA: Magnesium in human semen: possible role in premature ejaculation. Arch Androl. 2001 Jan-Feb;46(1):59-66.
  77. Vitamin D and male reproduction, Martin Blomberg Jensen, Nature Reviews Endocrinology 10, 175–186 (2014) doi:10.1038/nrendo.2013.262, Published online 14 January 2014. Source >>